Evidence map›Paper›PMID 37968728›Full record

ArticleCell & bioscience2023

Neurokinin-2 receptor negatively modulates substance P responses by forming complex with Neurokinin-1 receptor.

Lan Phuong Nguyen, Minyeong Cho, Thai Uy Nguyen, Hee-Kyung Park, Huong Thi Nguyen, Kateryna Mykhailova, Sunghoon Hurh, Hong-Rae Kim, Jae Young Seong, Cheol Soon Lee and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cell & bioscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 2 countries.

Lan Phuong NguyenDepartment of Biomedical Sciences, College of Medicine, Korea University, Seoul, Republic of Korea.
Minyeong ChoDepartment of Biomedical Sciences, College of Medicine, Korea University, Seoul, Republic of Korea.
Thai Uy NguyenDepartment of Biomedical Sciences, College of Medicine, Korea University, Seoul, Republic of Korea.
Hee-Kyung ParkDepartment of Biomedical Sciences, College of Medicine, Korea University, Seoul, Republic of Korea.
Huong Thi NguyenDepartment of Biomedical Sciences, College of Medicine, Korea University, Seoul, Republic of Korea.
Kateryna MykhailovaDepartment of Biomedical Sciences, College of Medicine, Korea University, Seoul, Republic of Korea.
Sunghoon HurhDepartment of Biomedical Sciences, College of Medicine, Korea University, Seoul, Republic of Korea.
Hong-Rae KimDepartment of Biomedical Sciences, College of Medicine, Korea University, Seoul, Republic of Korea.
Jae Young SeongDepartment of Biomedical Sciences, College of Medicine, Korea University, Seoul, Republic of Korea.
Cheol Soon LeeDepartment of Biomedical Sciences, College of Medicine, Korea University, Seoul, Republic of Korea.
Byung-Joo HamDepartment of Psychiatry, College of Medicine, Korea University, Seoul, Republic of Korea.
Jong-Ik HwangDepartment of Biomedical Sciences, College of Medicine, Korea University, Seoul, Republic of Korea. hjibio@korea.ac.kr.ORCID http://orcid.org/0000-0002-0729-1782
Korea University · KR

Funding

National research foundation of korea 2020M3E5D9080165National research foundation of korea 2022R1F1A1074216
6 · The paper itself

Abstract

backgroundTachykinins and their cognate receptors, neurokinin receptors (NKs) including NK1, NK2, and NK3 play vital roles in regulating various physiological processes including neurotransmission, nociception, inflammation, smooth muscle contractility, and stimulation of endocrine and exocrine gland secretion. Their abnormal expression has been reported to be associated with neurological disorders, inflammation, and cancer. Even though NKs are expressed in the same cells with their expression being inversely correlated in some conditions, there is no direct evidence to prove their interaction. Understanding the functional crosstalk between NKs in mediated downstream signaling and cellular responses may elucidate the roles of each receptor in pathophysiology.

resultsIn this study, we showed that NKs were co-expressed in some cells. However, different from NK3, which only forms homodimerization, we demonstrated a direct interaction between NK1 and NK2 at the protein level using co-immunoprecipitation and NanoBiT-based protein interaction analysis. Through heterodimerization, NK2 downregulated substance P-stimulated NK1 signals, such as intracellular Ca

conclusionOur study has provided the first direct evidence of an interaction between NK1 and NK2, which highlights the functional relevance of their heterodimerization in cellular responses. Our findings demonstrated that through dimerization, NK2 exerts negative effects on downstream signaling and cellular response mediated by NK1. Moreover, this study has significant implications for understanding the complexity of GPCR dimerization and its effect on downstream signaling and cellular responses. Given the important roles of tachykinins and NKs in pathophysiology, these insights may provide clues for developing NKs-targeting drugs.

Indexed as

Calcium signalingCell migrationERK phosphorylationGPCR dimerizationNegative modulationNeurokinin receptorsβ-arrestin

Identifiers

PMID37968728
PMCPMC10652611
OpenAlexW4388698678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.